Cuu Long Pharmaceutical JSC (HOSE:DCL)

HOSE:DCL Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	2,841,296	3,140,764	1,953,848	1,826,026	1,789,505	2,341,546
Market Cap Growth	73.66%	60.75%	7.00%	2.04%	-23.58%	63.49%
Enterprise Value	3,186,083	3,737,025	2,496,432	2,143,061	1,536,107	2,681,631
Last Close Price	38900.00	43000.00	26750.00	25000.00	24500.00	39800.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	-	160.93	37.89	30.58	16.47	27.89
PS Ratio	2.24	2.38	1.50	1.60	1.76	3.33
PB Ratio	1.87	2.07	1.30	1.26	1.29	2.43
P/TBV Ratio	1.92	2.12	1.34	1.30	1.32	2.63
P/OCF Ratio	22.65	65.72	27.99	81.05	-	79.54

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	2.51	2.83	1.91	1.87	1.51	3.81
EV/EBITDA Ratio	35.63	33.52	25.45	19.66	9.23	22.15
EV/EBIT Ratio	92.10	63.90	41.73	30.30	11.97	30.90

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.50	0.51	0.50	0.44	0.37	0.52
Debt / EBITDA Ratio	8.50	6.98	7.70	5.79	3.09	4.13
Net Debt / Equity Ratio	0.21	0.43	0.40	0.35	0.25	-0.06
Net Debt / EBITDA Ratio	3.63	5.85	6.10	4.70	2.12	-0.48
Net Debt / FCF Ratio	48.05	-16.20	-5.81	-2.56	-0.51	0.47
Asset Turnover	0.51	0.55	0.56	0.52	0.52	0.39
Inventory Turnover	2.81	3.17	3.10	2.75	2.35	1.84
Quick Ratio	1.10	1.15	1.29	1.33	1.50	1.22
Current Ratio	1.99	2.03	2.19	2.27	2.57	1.77
Return on Equity (ROE)	-0.11%	1.33%	3.67%	4.37%	9.59%	9.07%
Return on Assets (ROA)	0.88%	1.51%	1.59%	2.02%	4.13%	3.03%
Return on Invested Capital (ROIC)	-0.24%	1.58%	2.32%	3.04%	7.73%	8.10%
Return on Capital Employed (ROCE)	2.00%	3.30%	3.40%	4.30%	8.30%	8.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-0.08%	0.62%	2.74%	3.38%	6.24%	3.67%
FCF Yield	0.24%	-1.28%	-5.27%	-10.97%	-38.17%	-5.26%
Buyback Yield / Dilution	-	-	-	-4.11%	-22.02%	-1.17%
Total Shareholder Return	-	-	-	-4.11%	-22.02%	-1.17%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error